Sunlight and cancer

Cancer Causes and Control

Volumn 8, Issue 3, 1997, Pages 271-283

  English, Dallas R ^a   Armstrong, Bruce K ^b   Kricker, Anne ^c   Fleming, Claire ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b CANCER RESEARCH DIVISION   (Australia)

^c National Breast Cancer Center   (Australia)

Author keywords

Melanoma; Skin neoplasms; Sunlight

Indexed keywords

CYCLOBUTANE; CYTOSINE; DNA; PROTEIN P53; PYRIMIDINE; PYRIMIDINONE DERIVATIVE; SUNSCREEN; THYMINE; VITAMIN D;

BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER RISK; CARCINOGENICITY; DNA DAMAGE; FEMALE; GENE MUTATION; HUMAN; MALE; MELANOMA; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVIEW; SKIN CANCER; SQUAMOUS CELL CARCINOMA; SUN; SUN EXPOSURE; SUNBURN; SUNLIGHT; ULTRAVIOLET RADIATION;

AUSTRALIA; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CLIMATE; ENVIRONMENTAL EXPOSURE; EUROPE; EYE NEOPLASMS; FEMALE; HUMANS; MALE; MELANOMA; NEOPLASMS, RADIATION-INDUCED; OCCUPATIONAL EXPOSURE; RADIATION DOSAGE; SKIN NEOPLASMS; SUNLIGHT; SUNSCREENING AGENTS; ULTRAVIOLET RAYS;

EID: 0030757994     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018440801577     Document Type: Review

References (119)

1. de Gruijl FR. Photobiology of photocarcinogenesis. Photochem Photobiol 1996; 63: 372-5.
2. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J, eds. Cancer Incidence in Five Continents. Lyon, France: International Agency for Research on Cancer, 1992; IARC Sci. Pub. No. 120.
3. Armstrong BK. Melanoma of the skin. Br Med Bull 1984; 40: 346-50.
4. Bulliard JL, Cox B, Elwood JM. Latitude gradients in melanoma incidence and mortality in the non-Maori population of New Zealand. Cancer Causes Control 1994; 5: 234-40.
5. Khlat M, Vail A, Parkin DM, Green A. Mortality from melanoma in migrants to Australia: variation by age at arrival and duration of stay. Am J Epidemiol 1992; 135: 1103-13.
6. Iscovich J, Andreev H, Steinitz R. Incidence of cutaneous malignant melanoma in Israel, 1960-1989. Public Health Rev 1995; 23: 1-23.
7. Mack TM, Floderus B. Malignant melanoma risk by nativity, place of residence at diagnosis, and age at migration. Cancer Caues Control 1991; 2: 401-11.
8. Holman CD, Mulroney CD, Armstrong BK. Epidemiology of pre-invasive and invasive malignant melanoma in Western Australia. Int J Cancer 1980; 25: 317-23.
9. Lee JA, Strickland D. Malignant melanoma: social status and outdoor work. Br J Cancer 1980; 41: 757-63.
10. Cooke KR, Skegg DC, Fraser J. Socio-economic status, indoor and outdoor work, and malignant melanoma. Int J Cancer 1984; 34: 57-62.
11. Green A, Maclennan R, Youl P, Martin N. Site distribution of cutaneous melanoma in Queensland. Int J Cancer 1993; 53: 232-6.
12. Armstrong BK, English DR. Cutaneous malignant melanoma. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. Second Edition. New York, NY (USA): Oxford University Press, 1996.
13. White E, Kirkpatrick CS, Lee JA. Case-control study of malignant melanoma in Washington State. I. Constitutional factors and sun exposure. Am J Epidemiol 1994; 139: 857-68.
14. Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am J Epidemiol 1995; 141: 923-33.
15. International Agency for Research on Cancer. Solar and Ultraviolet Radiation. Lyon, France: IARC, 1992: IARC Monogr Eval Carcinog Risks Humans: 1-316.
16. Pion IA, Rigel DS, Garfinkel L, Silverman MK, Kopf AW. Occupation and the risk of malignant melanoma. Cancer 1995; 75: 637-44.
17. Autier P, Dore JF, Lejeune F, et al. Recreational exposure to sunlight and lack of information as risk factors for cutaneous malignant melanoma. Results of an European Organization for Research and Treatment of Cancer (EORTC) case-control study in Belgium, France and Germany. The EORTC Malignant Melanoma Cooperative Group. Melanoma Res 1994; 4: 79-85.
18. Autier R, Dore JF, Schifflers E, et al. Melanoma and use of sunscreens: an EORTC case-control study in Germany, Belgium and France. The EORTC Melanoma Cooperative Group. Int J Cancer 1995; 61: 749-55.
19. Westerdahl J, Olsson H, Ingvar C, Brandt L, Jonsson PE, Moller T. Southern travelling habits with special reference to tumour site in Swedish melanoma patients. Anticancer Res 1992; 12: 1539-42.
20. Westerdahl J, Olsson H, Ingvar C. At what age do sunburn episodes play a crucial role for the development of malignant melanoma? Eur J Cancer 1994; 30A: 1647-54.
21. Marghoob AA, Slade J, Salopek TG, Kopf AW, Bart RS, Rigel DS. Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma. Screening implications. Cancer 1995; 75: 707-14.
22. Goodman KJ, Bible ML, London S, Mack TM. Proportional melanoma incidence and occupation among White males in Los Angeles County (California, United States). Cancer Causes Control 1995; 6: 451-9.
23. Rodenas JM, Delgado-Rodriguez M, Herranz MT, Tercedor J, Serrano S. Sun exposure, pigmentary traits, and risk of cutaneous malignant melanoma - a case-control study in a Mediterranean population. Cancer Causes Control 1996; 7: 275-83.
24. Brown J, Kopf AW, Rigel DS, Friedman RJ. Malignant melanoma in World War II veterans. Int J Dermatol 1984; 23: 661-3.
25. Lê MG, Cabanes PA, Desvignes V, Chanteau MF, Mlika N, Avril MF. Oral contraceptive use and risk of cutaneous malignant melanoma in a case-control study of French women. Cancer Causes Control 1992; 3: 199-205.
26. Grob JJ, Gouvernet J, Aymar D, et al. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 1990; 66: 387-95.
27. Vågerö D, Ringbäck G, Kiviranta H. Melanoma and other tumours of the skin among office, other indoor and outdoor workers in Sweden 1961-1979. Br J Cancer 1986; 53: 507-12.
28. Beral V, Robinson N. The relationship of malignant melanoma, basal and squamous skin cancers to indoor and outdoor work. Br J Cancer 1981; 44: 886-91.
29. Nelemans PJ, Rampen FH, Ruiter DJ, Verbeek AL. An addition to the controversy on sunlight exposure and melanoma risk: a meta-analytical approach. J Clin Epidemiol 1995; 48: 1331-42.
30. World Health Organization. Ultraviolet Radiation (Environmental Health Criteria 160). Geneva, Switzerland: WHO, 1994.
31. Elwood JM, Gallagher RP, Hill GB, Pearson JC. Cutaneous melanoma in relation to intermittent and constant sun exposure - the Western Canada Melanoma Study. Int J Cancer 1985; 35: 427-33.
32. Elwood JM, Gallagher RP. Sun exposure and the epidemiology of melanoma. In: Gallagher RP, Elwood ME, eds. Epidemiological Aspects of Cutaneous Malignant Melanoma. Boston, MA (USA): Kluwer Academic Publishers, 1994: 15-66.
33. Westerdahl J, Olsson H, Masback A, Ingvar C, Jonsson N. Is the use of sunscreens a risk factor for malignant melanoma? Melanoma Res 1995; 5: 59-65.
34. Kricker A, Armstrong BK, English DR. Sun exposure and non-melanocytic skin cancer. Cancer Causes Control 1994; 5: 367-92.
35. Scotto J, Fears TR, Fraumeni JF Jr. Incidence of Non-melanoma Skin Cancer in the United States. Bethesda, MD (USA): US Department of Health and Human Services, 1983; NIH Pub. No. 82-2433.
36. Kricker A, Armstrong BK, English DR, Heenan PJ. Pigmentary and cutaneous risk factors for non-melanocytic skin cancer - a case-control study. Int J Cancer 1991; 48: 650-62.
37. Marks R, Staples M, Giles GG. Trends in non-melanocytic skin cancer treated in Australia: the second national survey. Int J Cancer 1993; 53: 585-90.
38. Molesworth EH. Rodent ulcer. Med J Aust 1927; 1: 878-99.
39. Blum H. Sunlight as a causal factor in cancer of the skin in man. JNCI 1948; 9: 247-58.
40. Emmett EA. Ultraviolet radiation as a cause of skin tumors. CRC Critical Reviews m Toxicology 1973; 2: 211-55.
41. Marks R, Jolley D, Dorevitch AP, Selwood TS. The incidence of non-melanocytic skin cancers in an Australian population: results of a five-year prospective study. Med J Aust 1989; 150: 475-8.
42. Vitasa BC, Taylor HR, Strickland PT, et al. Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer 1990; 65: 2811-7.
43. Hunter DJ, Colditz GA, Stampfer MJ, Rosner B, Willett WC, Speizer FE. Risk factors for basal cell carcinoma in a prospective cohort of women. Ann Epidemiol 1990; 1: 13-23.
44. Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 1995; 131: 157-63.
45. Kricker A, Armstrong BK, English DR, Heenan PJ. A dose-response curve for sun exposure and basal cell carcinoma. Int J Cancer 1995; 60: 482-8.
46. Rosso S, Zanetti R, Martinez C, et al. The multicentre South European Study, 'Helios.' 2. Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer 1996; 73: 1447-54.
47. Zanetti R, Rosso S, Martinez C, et al. The multicentre South European Study, 'Helios.' 1. Skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin. Br J Cancer 1996; 73: 1440-6.
48. Kricker A, Armstrong BK, English DR, Heenan PJ. Does intermittent sun exposure cause basal cell carcinoma? A case-control study in Western Australia. Int J Cancer 1995; 60: 489-94.
49. Hogan DJ, To T, Gran L, Wong D, Lane PR. Risk factors for basal cell carcinoma. Int J Dermatol 1989; 28: 591-4.
50. Green A, Battistutta D. Incidence and determinants of skin cancer in a high-risk Australian population. Int J Cancer 1990; 46: 356-61.
51. Strickland PT, Vitasa BC, West SK, et al. Quantitative carcinogenesis in man: solar ultraviolet B dose dependence of skin cancer in Maryland watermen. JNCI 1989; 81: 1910-3.
52. Magnus K. The Nordic profile of skin cancer incidence. A comparative epidemiological study of the three main types of skin cancer. Int J Cancer 1991; 47: 12-9.
53. Urbach F. Geographic pathology of skin cancer In: Urbach F, ed. Biologic Effects of UVR with Emphasis on the Skin. Oxford, UK: Pergamon Press, 1969: 635-50.
54. Grodstein F, Speizer FE, Hunter DJ. A prospective study of incident squamous cell carcinoma of the skin in the Nurses' Health Study. JNCI 1995; 87: 1061-6.
55. Ramani ML, Bennett RG. High prevalence of skin cancer in World War II servicemen stationed in the Pacific theater. J Am Acad Dermatol 1993; 28: 733-7.
56. Urbach F, Rose DB, Bonnem M. Genetic and environmental interactions in skin carcinogenesis. Environmental Cancer. Baltimore, MD (USA): Williams & Wilkins, 1972: 355-71.
57. Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer. II. Squamous cell carcinoma. Arch Dermatol 1995; 131: 164-9.
58. Hogan DJ, Lane PR, Gran L, Wong D. Risk factors for squamous cell carcinoma of the skin in Saskatchewan, Canada. J Dermatol Sci 1990; 1: 97-101.
59. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993; 329: 1147-51.
60. Naylor MF, Boyd A, Smith DW, Cameron GS, Hubbard D, Neldner KH. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol 1995; 131: 170-5.
61. Lerman S. Light induced changes in ocular tissues. In: Miller D, ed. Clinical Light Damage to the Eye. New York, NY (USA): Springer-Verlag, 1987: 183-215.
62. Neugut AI, Kizelnik-Freilich S, Ackerman C. Black-white differences in risk for cutaneous, ocular, and visceral melanomas. Am J Public Health 1994; 84: 1828-9.
63. Polednak AP, Flannery JT. Brain, other central nervous system, and eye cancer. Cancer 1995; 75: 330-7.
64. Raivio I. Uveal melanoma in Finland. An epidemiological, clinical, histological and prognostic study. Acta Ophthalmol 1977; Suppl: 1-64.
65. Scotto J, Fraumeni JF Jr, Lee JA. Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. JNCI 1976; 56: 489-91.
66. Gislason I, Magnusson B, Tulinius H. Malignant melanoma of the uvea in Iceland 1955-1979. Acta Ophthalmol (Copenh) 1985; 63: 389-94.
67. Schwartz SM, Weiss NS. Place of birth and incidence of ocular melanoma in the United States. Int J Cancer 1988; 41: 174-7.
68. Doll R. Urban and rural factors in the aetiology of cancer. Int J Cancer 1991; 47: 803-10.
69. Iscovich J, Ackerman C, Andreev H, Pe'er J, Steinitz R. An epidemiological study of posterior uveal melanoma in Israel, 1961-1989. Int J Cancer 1995; 61: 291-5.
70. Saftlas AF, Blair A, Cantor KP, Hanrahan L, Anderson HA. Cancer and other causes of death among Wisconsin farmers. Am J Ind Med 1987; 11: 119-29.
71. Gallagher RP, Elwood JM, Rootman J. Epidemiologic aspects of intraocular malignant melanoma. Cancer Treat Res 1988; 43: 73-84.
72. Milham SJ. Occupational Mortality in Washington State 1950-1979. Cincinnati, OH (USA): National Institute for Occupational Safety and Health. 1983; DHSS (NIOSH) Pub. No. 83-116.
73. Office of the Population Censuses and Surveys. Occupational Mortality: the Registrar General's Decennial Supplement for Great Britain 1979-80, 1982-83. London, UK: Her Majesty's Stationery Office, 1986; Series DS No. 6.
74. Vägerö D, Swerdlow AJ, Beral V. Occupation and malignant melanoma: a study based on cancer registration data in England and Wales and in Sweden. Br J Ind Med 1990; 47: 317-24.
75. Horn EP, Hartge P, Shields JA, Tucker MA. Sunlight and risk of uveal melanoma. JNCI 1994; 86: 1476-8.
76. Coroneo MT, Muller-Stolzenburg NW, Ho A. Peripheral light focusing by the anterior eye and the ophthalmohelioses. Ophthalmic Surg 1991; 22: 705-11.
77. Narayanan P, Merriam JC, Vazquez MK, Dillon J. Experimental model of light focusing of the peripheral cornea. Invest Ophthalmol Vis Sci 1996; 37: 37-41.
78. Holly EA, Aston DA, Char DH, Kristiansen JJ, Ahn DK. Uveal melanoma in relation to ultraviolet light exposure and host factors. Cancer Res 1990; 50: 5773-7.
79. Van Hees CL, De Boer A, Jager MJ, et al. Are atypical nevi a risk factor for uveal melanoma? A case-control study. J Invest Dermatol 1994; 103: 202-5.
80. Gallagher RP, Elwood JM, Rootman J, et al. Risk factors for ocular melanoma: Western Canada Melanoma Study. JNCI 1985; 74: 775-8.
81. Tucker MA, Shields JA, Hange P, et al. Sunlight exposure as risk factor for intraocular malignant melanoma. N Engl J Med 1985; 313: 789-92.
82. Seddon JM, Gragoudas ES, Glynn RJ, Egan KM, Albert DM, Blitzer PH. Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Arch Ophthalmol 1990; 108: 1274-80.
83. Ajani UA, Seddon JM, Hsieh C-c, Egan KM, Albert DM, Gragoudas ES. Occupation and risk of uveal melanoma. An exploratory study. Cancer 1992; 70: 2891-900.
84. Holly EA, Aston DA, Ahn DK, et al. Intraocular melanoma linked to occupations and chemical exposures. Epidemiology 1996; 7: 55-61.
85. Ni C, Searl SS, Kriegstein HJ, Wu BF. Epibulbar carcinoma. Int Ophthalmol Clin 1982; 22: 1-33.
86. Newton R, Ferlay J, Reeves G, Beral V, Parkin DM. Effect of ambient solar ultraviolet radiation on incidence of squamous-cell carcinoma of the eye. Lancet 1996; 347: 1450-1.
87. Lee GA, Williams G, Hirst LW, Green AC. Risk factors in the development of ocular surface epithelial dysplasia. Opthalmology 1994; 101: 360-4.
88. Hall P, Rosendahl I, Mattsson A, Einhorn S. Non-Hodgkin's lymphoma and skin malignancies - shared etiology? Int J Cancer 1995; 62: 519-22.
89. Adami J, Frisch M, Yuen J, Glimelius B, Melbye M. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. Br Med J 1995; 310: 1491-5.
90. Frisch M, Melbye M. New primary cancers after squamous cell skin cancer. Am J Epidemiol 1995; 141: 916-22.
91. Levi F, Randimbison L, Te VC, La Vecchia C. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. Br J Cancer 1996; 74: 1847-50.
92. Frisch M, Hjalgrim H, Olsen JH, Melbye M. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Int Med 1996; 125: 815-21.
93. Wassberg C, Thorn M, Yuen J, Ringborg U, Hakulinen T. Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden. Br J Cancer 1996; 73: 255-9.
94. McMichael AJ, Giles GG. Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma? Br J Cancer 1996; 73: 945-50.
95. Hartge P, Devesa SS, Grauman D, Fears TR, Fraumeni JF Jr. Non-Hodgkin's lymphoma and sunlight. JNCI 1996; 88: 298-300.
96. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 1980; 9: 227-31.
97. Garland FC, Garland CF, Gorham ED, Young JF. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 1990; 19: 614-22.
98. Emerson JC, Weiss NS. Colorectal cancer and solar radiation. Cancer Causes Control 1992; 3: 95-9.
99. Gorham ED, Garland FC, Garland CF. Sunlight and breast cancer incidence in the USSR. Int J Epidemiol 1990; 19: 820-4.
100. Brash DE. UV mutagenic photoproducts in Escherichia coli and human cells: a molecular genetics perspective on human skin cancer. Photochem Photobiol 1988; 48: 59-66.
101. Freeman SE, Hacham H, Gange RW, Maytum DJ, Sutherland JC, Sutherland BM. Wavelength dependence of pyrimidine dimer formation in DNA of human skin irradiated in situ with ultraviolet light. Proc Natl Acad Sci USA 1989; 86: 5605-9.
102. Sage E. Distribution and repair of photolesions in DNA: genetic consequences and the role of sequence context. Photochem Photobiol 1993; 57: 163-74.
103. Hutchinson F. Induction of tandem-base change mutations. Mutat Res 1994; 309: 11-5.
104. Kraemer KH, Lee MM, Andrews AD, Lambert WC. The role of sunlight and DNA repair in melanoma and non-melanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 1994; 130: 1018-21.
105. Bridges B. Sunlight, DNA damage and skin cancer: a new perspective. Jpn J Cancer Res 1990; 81: 105-7.
106. Barrett SF, Robbins JH, Tarone RE, Kraemer KH. Evidence for defective repair of cyclobutane pyrimidine dimers with normal repair of other DNA photoproducts in a transcriptionally active gene transfected into Cockayne syndrome cells. Mutat Res 1991; 255: 281-91.
107. Brash DE, Rudolph JA, Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991; 88: 10124-8.
108. Pierceall WE, Mukhopadhyay T, Goldberg LH, Ananthaswamy HN. Mutations in the p53 tumor suppressor gene in human cutaneous squamous cell carcinomas. Mol Carcinog 1991; 4: 445-9.
109. Ziegler A, Leffell DJ, Kunala S, et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA 1993; 90: 4216-20.
110. Rady P, Scinicariello F, Wagner RF Jr, Tyring SK. p53 mutations in basal cell carcinomas. Cancer Res 1992; 52: 3804-6.
111. Molès JP, Moyret C, Guillot B, et al. p53 gene mutations in human epithelial skin cancers. Oncogene 1993; 8: 583-8.
112. Burns JE, Baird MC, Clark LJ, et al. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. Br J Cancer 1993; 67: 1274-84.
113. van der Riet P, Karp D, Farmer E, et al. Progression of basal cell carcinoma through loss of chromosome 9q and inactivation of a single p53 allele. Cancer Res 1994; 54: 25-7.
114. Ziegler A, Jonason AS, Leffell DJ, et al. Sunburn and p53 in the onset of skin cancer. Nature 1994; 372: 773-6.
115. Ziegler A, Jonason AS, Simon J, Leffell DJ, Brash DE. Tumor suppressor gene mutations and photocarcinogenesis. Photochem Photobiol 1996; 63: 432-5.
116. Nakazawa H, English D, Randell PL, et al. UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc Natl Acad Sci USA 1994; 91: 360-4.
117. Daya-Grosjean L, Dumaz N, Sarasin A. The specificity of p53 mutation spectra in sunlight induced human cancers. J Photochem Photobiol B 1995; 28: 115-24.
118. Pollock PM, Pearson JV, Hayward NK. Compilation of somatic mutations of the CDKN2 gene in human cancers - non-random distribution of base substitutions. Genes Chromosom Cancer 1996; 15: 77-88.
119. Gailani MR, Leffell DJ, Ziegler A, Gross EG, Brash DE, Bale AE. Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma. JNCI 1996; 88: 349-54.